Public Calls for Stricter Ova Regulation
By The Korea Times,
The Korea Times
| 01. 12. 2006
Voices are getting louder over the revision of the bioethics law amid allegations that female researchers of Prof. Hwang Woo-suk's team were forced to donate their ova for stem cell experiments.
Prof. Chung Myung-hee, head of the Seoul National University (SNU) panel investigating Hwang's fabrication of research data, announced Tuesday that a total of 2,061 eggs from 129 females were collected from four hospitals and provided to his team for three years from November 2002.
The key question is whether Hwang's team has violated the bioethics law that took effect in January last year.
The law forbids the trade of sperm and ova for commercial purposes. It stipulates that those offering ovum for a commercial purpose are subject to prison terms of up to three years and those arranging the illegal trade may face imprisonment of up to two years.
In short, if egg-donation takes place voluntarily without commercial benefits, it is not punishable. In addition, those who were involved even in commercial ova trading that took place before 2005 are not subject to any punishment.
Cloning scientist Hwang admitted...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...